Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D00DBH
|
|||
Former ID |
DIB000447
|
|||
Drug Name |
NPS 1776
|
|||
Synonyms |
Isovaleramide
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Epilepsy [ICD-11: 8A60-8A68] | Discontinued in Phase 2 | [1] | |
Company |
NPS Pharmaceuticals
|
|||
Structure |
Download2D MOL |
|||
Formula |
C5H11NO
|
|||
Canonical SMILES |
CC(C)CC(=O)N
|
|||
InChI |
1S/C5H11NO/c1-4(2)3-5(6)7/h4H,3H2,1-2H3,(H2,6,7)
|
|||
InChIKey |
SANOUVWGPVYVAV-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 541-46-8
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Fatty aldehyde dehydrogenase (ALDH3A2) | Target Info | Modulator | [2] |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800010984) | |||
REF 2 | Diverse Mechanisms of Antiepileptic Drugs in the Development Pipeline. Epilepsy Res. 2006 June; 69(3): 273-294. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.